The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.

Kometer, Michael

The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations. [electronic resource] - Biological psychiatry Mar 2011 - 399-406 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1873-2402

10.1016/j.biopsych.2010.10.002 doi


Adult
Cluster Analysis
Consciousness Disorders--psychology
Dose-Response Relationship, Drug
Electroencephalography--drug effects
Female
Hallucinogens--pharmacology
Humans
Male
Neuropsychological Tests
Occipital Lobe--drug effects
Parkinson Disease--complications
Perceptual Closure--physiology
Photic Stimulation
Psilocybin--pharmacology
Psychometrics
Reaction Time--physiology
Receptor, Serotonin, 5-HT1A--drug effects
Receptor, Serotonin, 5-HT2A--drug effects
Schizophrenia--complications
Serotonin Receptor Agonists--pharmacology
Visual Cortex--drug effects